MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202641072907 A) filed by Saveetha Institute Of Medical And Technical Sciences on June 12, 2026, for Therapeutic Potential Of Biopolymer Based C-Optiheal Dm Spray For Infected Diabetic Ulcers.
Inventors include Dr. Chella Perumal Palanisamy; Niranjan Balaji; Dr. Gopalakrishnan Velliyur Kanniappan; Dr. Rajkumar Thamarai; Dr. Kaliyamoorthy Dass; Dr. Venkatesan Karthick; Dr. Selvaraj Jayaraman; Dr. Nishab; and Dr. Deepak Nallaswamy Veeraiyan.
The application for the patent was published on July 03, 2026, under issue no. 27/2026.
Abstract: The present invention discloses a bio-polymer based spray formulation designated as C- OptiHeal-DM developed for the treatment of infected diabetic ulcers. The formulation comprises an aqueous leaf extract of Moringa oleifera integrated into a chitosan—alginate polyelectrolyte complex along with pharmaceutically acceptable stabilizing and viscositymodifying agents. The electrostatic interaction between chitosan and alginate results in formation of a structured polymeric network capable of sustained and localized release of plant- derived bioactive constituents. The developed spray demonstrates antimicrobial activity against wound-associated pathogens, antioxidant potential, and cytocompatibility with mammalian skin cell lines under in vitro conditions. The spray delivery system ensures uniform wound surface coverage, supports moisture balance, and provides a stable and scalable therapeutic platform for infected diabetic ulcer management.
Disclaimer: Curated by HT Syndication.
